NGS, SCA, SMA & Mass Spec: Research to Diagnostics 2016

Home
|
Posters
|

Training Courses

|
Media
|

Keynote Speakers

Alexander Asanov Chief Scientific Officer, TIRF Labs, Inc.	Martyn Boutelle Professor of Biomedical Sensors Engineering, Imperial College London	Jennifer Friedman Clinical Professor of Neurosciences and Pediatrics, Rady Children's Hospital in San Diego	James Heath Elizabeth W. Gilloon Professor of Chemistry, California Institute of Technology (CalTech)	Jason Heikenfeld Professor and VP Operations, UC Office of Innovation, University of Cincinnati	James Hickman Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos
Abraham Lee Chancellor’s Professor, Biomedical Engineering & Director, Center for Advanced Design & Manufacturing of Integrated Microfluidics, University of California-Irvine	Minetta Liu Associate Professor and Chair, Oncology Research, Mayo Clinic	Tingrui Pan Professor, Department of Biomedical Engineering, University of California-Davis	Kamlesh Patel R&D Advanced System Engineering and Deployment Manager, Sandia National Laboratories	Lidong Qin Professor and CPRIT Scholar, Houston Methodist Research Institute	Juan Santiago Charles Lee Powell Foundation Professor, Stanford University
Gary Schroth Vice President and Distinguished Scientist, Illumina	Gary Siuzdak Professor and Director, The Scripps Research Institute	Steve Soper Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas	Bernhard Weigl Director, Center for In-Vitro Diagnostics, Intellectual Ventures/Global Good-Bill Gates Venture Fund	Aaron Wheeler Canada Research Chair of Bioanalytical Chemistry, University of Toronto	Alan Wright Chief Medical Officer, Roche Diagnostics Corporation
Weian Zhao Associate Professor, Department of Biomedical Engineering, University of California-Irvine

Overview

This conference brings together technology development and applications of:

Next-Generation Sequencing (NGS)
Single Cell Analysis (SCA)
Single Molecule Analysis (SMA)
Mass Spectrometry

Technology development in these fields is occurring in parallel with advances in Lab-on-a-Chip/Microfluidics and the broader push in diagnostics development, and in this vein this conference is co-located and concurrent with the following conferences at the same venue and at the same time:

1. Lab-on-a-Chip and Microfluidics: Emerging Themes, Technologies and Applications
2. Lab-on-a-Chip and Microfluidics: Techologies and Commercialization
3. Point-of-Care Diagnostics & Global Health World Congress 2016
4. Next-Generation Sequencing (NGS), Single-Cell Analysis (SCA), Single Molecule Analysis (SMA) & Mass Spectrometry: Research to Diagnostics 2016

It has become increasingly apparent that the differences between cells in the same population can be significant, and there is therefore a need for improved methods to capture and analyze individual cells such as circulating tumor cells (CTCs). The development of technologies for single cell analysis (SCA) is driving this field forward via basic research on isolated individual cells, the development of biomarker assays, and diagnostics development.

We also explore at this conference the translation of next-generation sequencing (NGS) from research to deployment in the clinical-setting for oncology, genetic testing, as well as infectious disease testing. As NGS permeates the cancer biomarker and genetic testing realms and cost of NGS declines, there is the opportunity and hope to deploy NGS as a means to personalize diagnostics and therapeutics -- this is one of the themes explored in the NGS section of this conference.

This conference will also present the latest technologies/products in flow cytometry, FISH, immunoma

Agenda Topics

Flow Cytometry, FISH and Technologies for Single Cell Analysis (SCA)
Front-end Sample Preparation for NGS -- Challenges with Clinic Samples
Microfluidic Devices for Single Cell Analysis (SCA)
NGS in Non-Invasive Prenatal Testing (NIPT)
NGS on Rare Cells (such as Circulating Tumor Cells)
Sample Preparation for Mass Spectrometry — Challenges Posed by Clinical Samples and the Need for Robustness, Scale and Automation for Diagnostics

LC/MS for Clinical Diagnostics
Mass Spectrometry for Biofluid Biomarker Analysis

Single Cell Analysis (SCA) and Single Molecule Analysis (SMA) for Diagnostics Development and Genetic, Prenatal Testing
Single Cell Analysis (SCA) and Single Molecule Analysis (SMA) in Cancer, CNS Diseases, and Other Disease Classes
Single Cell Transcriptomics and Proteomics

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Distinguished Faculty

Yong Zeng, Associate Professor, University of Florida
John Nolan, CEO, Cellarcus Biosciences, Inc.
Eric Kaldjian, Chief Medical Officer, RareCyte
Lyle Arnold, Chief Scientific Officer, Biocept
Charles Wang, Director & Professor, Loma Linda University
Erick Lin, Director of Medical Affairs, Ambry Genetics
Rajiv Bharadwaj, Director, Microfluidics, 10x Genomics
Nazneen Aziz, Executive Director, Kaiser Permanente Research Bank
Utkan Demirci, Professor, Stanford University School of Medicine
Yu-Hwa Lo, Professor, University of California San Diego
Kendall Van Keuren-Jensen, Professor and Deputy Director, Translational Genomics Research Institute
Kun Zhang, Professor, Department of Bioengineering, University of California San Diego
Martin Siaw, Vice President of Science and Innovation, BasePrime Genomics

Corporate Sponsors	Web Sponsors	Offical Journal Partner	Networking